Expression and structure of the human NGF receptor, Cell, vol.47, pp.545-554, 1986. ,
Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptorinduced apoptosis, Nat Genet J Biol Chem, vol.22, issue.271, pp.366-3694961, 1996. ,
FLICE, A Novel FADD-Homologous ICE/CED-3???like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex, Cell, vol.85, issue.6, pp.817-827, 1996. ,
DOI : 10.1016/S0092-8674(00)81266-0
Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death, Cell, vol.85, pp.803-815, 1996. ,
Molecular ordering of the Fas-apoptotic pathway: the Fas ,
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, Embo J, vol.14, pp.5579-5588, 1995. ,
The death domain superfamily: a tale of two interfaces?, Trends Biochem Sci, vol.26, pp.475-481, 2001. ,
An induced proximity model for caspase-8 activation, J Biol Chem, vol.273, pp.2926-2930, 1998. ,
Apoptosis in the pathogenesis and treatment of disease, Science, vol.267, pp.1456-1462, 1995. ,
Casper is a FADD-and caspase-related inducer of apoptosis, Immunity, vol.6, pp.751-763, 1997. ,
FLAME-1, a novel FADDlike anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis, J Biol Chem, vol.272, pp.18542-18545, 1997. ,
CASH, a novel caspase homologue with death effector domains, J Biol Chem, vol.272, pp.19641-19644, 1997. ,
I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis, J Biol Chem, vol.272, pp.17255-17257, 1997. ,
Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex, Cell Death Differ, vol.5, pp.271-288, 1998. ,
Fas engagement induces neurite growth through ERK activation and p35 upregulation, Nat Cell Biol, vol.5, pp.118-125, 2003. ,
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally, Immunity, vol.9, pp.267-276, 1998. ,
Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domainlike interleukin 1-converting enzyme inhibitory protein expression, Cancer Res, vol.60, pp.3947-3956, 2000. ,
Chemotherapy enhances TNF-related apoptosis-inducing Ligand DISC assembly in HT29 human colon cancer cells Doxorubicin Pretreatment Sensitizes Prostate Cancer Cell Lines to TRAIL Induced Apoptosis Which Correlates with the Loss of c-FLIP Expression, Oncogene Cancer Biol Ther, vol.22, issue.1, pp.1807-1816520, 2002. ,
Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression, Int J Cancer, vol.88, pp.986-991, 2000. ,
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells, Oncogene, vol.20, issue.10, pp.5225-5231, 2001. ,
An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis, J Biol Chem, vol.277, pp.22320-22329, 2002. ,
Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis, J Neuroimmunol, vol.120, pp.199-207, 2001. ,
c-FLIP efficiently rescues TRAF-2-/-cells from TNF-induced apoptosis, Cell Death Differ, vol.9, pp.138-144, 2002. ,
Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIP, Mol Cell Biol, vol.23, pp.1278-1291, 2003. ,
Phosphatidylinositol 3- kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP), Circ Res, vol.89, pp.13-19, 2001. ,
Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells, J Biol Chem, vol.276, pp.6893-6896, 2001. ,
Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway, Oncogene, vol.21, pp.337-346, 2002. ,
Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression, J Exp Med, vol.188, issue.10, pp.1795-1802, 1998. ,
Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis, J Biol Chem, vol.277, pp.21723-21729, 2002. ,
Stem Cell Factor increases the expression of FLIP which inhibits IFN{gamma}-induced apoptosis in human erythroid progenitor cells 10:10. 76 Calcium/calmodulindependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells, Blood J Biol Chem, vol.278, pp.7043-7050, 2002. ,
Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein, Endocrinology, vol.144, pp.623-630, 2003. ,
Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis, J Biol Chem, vol.278, pp.454-461, 2003. ,
Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines, J Immunol, vol.168, pp.2544-2553, 2002. ,
Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways, Cell Death Differ, vol.10, pp.124-133, 2003. ,
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency, Nature, vol.419, pp.395-399, 2002. ,
First indication of caspase-8 mutations leading to human immunodeficiency Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis, J Immunol, vol.83, issue.162, pp.5205-5211, 1999. ,
Autoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes, Immunity, vol.30, issue.4, pp.763-770, 1999. ,
DOI : 10.1016/j.immuni.2009.04.003
Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease WELLINGTON CL, HAYDEN MR: Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases, Cellular and Molecular Neurobiology, vol.22, issue.5/6, pp.545-5631, 2000. ,
DOI : 10.1023/A:1021832302524
Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling, J Biol Chem, vol.277, pp.7720-7725, 2002. ,
Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis, Brain, vol.125, pp.2036-2043, 2002. ,
Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death, Mol Cell Biol, vol.19, pp.751-763, 1999. ,
Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury, J Neurosci, vol.18, pp.5124-5135, 1998. ,
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation, Blood, vol.101, pp.1956-1961, 2003. ,
Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease, Biochem Biophys Res Commun, vol.281, pp.84-93, 2001. ,
The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain, Neurochem Res, vol.28, pp.307-318, 2003. ,
T-cell responses to oligodendrocyte-specific protein in multiple sclerosis, Journal of Neuroscience Research, vol.105, issue.3, pp.506-509, 2001. ,
DOI : 10.1002/jnr.1241
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls, J Neuroimmunol, vol.114, issue.10, pp.220-225, 2001. ,
A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic, Neurology, vol.53, pp.154-161, 1999. ,
Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease, J Neuroimmunol, vol.100, pp.42-52, 1999. ,
Multiple sclerosis: Fas signaling in oligodendrocyte cell death, J Exp Med, vol.184, pp.2361-2370, 1996. ,
Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy, J Neuroimmunol, vol.75, pp.141-146, 1997. ,
Association of a CA repeat polymorphism upstream of the Fas ligand gene with multiple sclerosis, J Neuroimmunol, vol.116, pp.238-241, 2001. ,
Expression of the Long Form of Human FLIP by Retroviral Gene Transfer of Hemopoietic Stem Cells Exacerbates Experimental Autoimmune Encephalomyelitis, J Immunol, vol.170, pp.2064-2073, 2003. ,
Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis, J Neuroimmunol, vol.113, issue.10, pp.268-274, 2001. ,
Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells, Endocrinology, vol.139, pp.2032-2040, 1998. ,
Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis, J Rheumatol, vol.23, pp.1332-1337, 1996. ,
T cell receptor of Fas-sensitive T cells in rheumatoid synovium, J Immunol, vol.158, pp.1965-1970, 1997. ,
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL, Nat Immunol, vol.4, pp.255-260, 2003. ,
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?, Annu Rev Immunol, vol.19, pp.163-196, 2001. ,
Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand, Arthritis Rheum, vol.40, pp.1054-1063, 1997. ,
Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta- converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis, Arthritis Rheum, vol.44, pp.21-30, 2001. ,
Contribution of Fas to diabetes development, Proc Natl Acad Sci U S A, vol.100, pp.628-632, 2003. ,
Suppression of Fas-FasLinduced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes, Faseb J, vol.17, pp.76-78, 2003. ,
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy, Lancet, vol.347, issue.10, pp.1151-1155, 1996. ,
Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factoralpha, Circ Res, vol.81, pp.627-635, 1997. ,
Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure, Am J Physiol Heart Circ Physiol, vol.284, pp.268-276, 2003. ,
Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues, Cardiovasc Res, vol.48, pp.101-110, 2000. ,
Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation, Arterioscler Thromb Vasc Biol, vol.20, pp.298-308, 2000. ,
Expression of cellular FLICEinhibitory protein in human coronary arteries and in a rat vascular injury model, Am J Pathol, vol.156, pp.125-137, 2000. ,
Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling, Immunol Rev, vol.169, pp.283-302, 1999. ,
FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis, Science, vol.279, pp.1954-1958, 1998. ,
Lessons from hereditary colorectal cancer, Cell, vol.87, issue.10, pp.159-170, 1996. ,
Genetic instabilities in human cancers, Nature, vol.396, pp.643-649, 1998. ,
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, Nat Med, vol.7, pp.94-100, 2001. ,
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development, J Exp Med, vol.195, pp.161-169, 2002. ,
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gammadependent suppression of subcutaneous tumor growth, Cell Immunol, vol.214, pp.194-200, 2001. ,
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis, J Exp Med, vol.193, pp.661-670, 2001. ,
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety, J Pharmacol Exp Ther, vol.299, pp.31-38, 2001. ,
Defective death receptor signaling as a cause of tumor immune escape, Semin Cancer Biol, vol.12, pp.51-55, 2002. ,
Inhibition of death receptor signaling by FLICEinhibitory protein as a mechanism for immune escape of tumors, J Exp Med, vol.190, pp.891-894, 1999. ,
Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line, Leukemia, vol.14, pp.2149-2158, 2000. ,
Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma, Blood, vol.94, pp.1727-1737, 1999. ,
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells, Am J Pathol, vol.160, pp.1521-1528, 2002. ,
Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein, J Exp Med, vol.190, pp.1033-1038, 1999. ,
Increased expression of cFLIP(L) in colonic adenocarcinoma, J Pathol, vol.194, pp.15-19, 2001. ,
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells, J Immunol, vol.161, pp.2833-2840, 1998. ,
Selective expression of FLIP in malignant melanocytic skin lesions, J Invest Dermatol, vol.117, pp.360-364, 2001. ,
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release, FEBS Lett, vol.473, pp.27-32, 2000. ,
Relation of TNF-related apoptosisinducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma, Cancer Res, vol.59, pp.2747-2753, 1999. ,
The Bcl2 family: regulators of the cellular life-or-death switch, Nat Rev Cancer, vol.2, pp.647-656, 2002. ,
A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells, J Immunol, vol.167, pp.2068-2073, 2001. ,
Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice, J Immunol, vol.167, pp.4230-4237, 2001. ,
Nature's TRAIL-On a Path to Cancer Immunotherapy, Immunity, vol.18, pp.1-6, 2003. ,
Sensitization for death receptor-or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer, Oncogene, vol.20, pp.5865-5877, 2001. ,
Induction of apoptosis by cancer chemotherapy, Exp Cell Res, vol.256, pp.42-49, 2000. ,
Selection for drug resistance results in resistance to Fas-mediated apoptosis, Blood, vol.89, issue.10, pp.1854-1861, 1997. ,
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis, Int J Cancer, vol.99, pp.491-504, 2002. ,
Sensitization of human colon cancer cells to TRAIL-mediated apoptosis, J Gastrointest Surg, vol.5, pp.56-65, 2001. ,
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines, Cancer Res, vol.59, pp.734-741, 1999. ,
Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis, Cancer Res, vol.61, pp.1645-1651, 2001. ,
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice, Cancer Res, vol.62, pp.5800-5806, 2002. ,
Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein, J Thorac Cardiovasc Surg, vol.123, pp.168-174, 2002. ,
Tumor necrosis factor-related apoptosisinducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines, Am J Respir Cell Mol Biol, vol.25, pp.111-118, 2001. ,
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo, Cancer Res, vol.60, pp.847-853, 2000. ,
Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells, Cancer Chemother Pharmacol, vol.50, issue.10, pp.46-52, 2002. ,
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells, Gynecol Oncol, vol.81, pp.380-390, 2001. ,
Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells, Cell Death Differ, vol.9, pp.287-300, 2002. ,
Safety and antitumor activity of recombinant soluble Apo2 ligand, J Clin Invest, vol.104, pp.155-162, 1999. ,
Downregulation of c-FLIP Sensitizes DU145 Prostate Cancer Cells to Fas-Mediated Apoptosis, Cancer Biol Ther, vol.1, pp.401-406, 2002. ,
Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells, Am J Pathol, vol.161, issue.10, pp.643-654, 2002. ,
Selective Inhibition of FLICE-like Inhibitory Protein Expression With Small Interfering RNA Oligonucleotides Is Sufficient to Sensitize Tumor Cells for TRAIL-Induced Apoptosis, Mol Med, vol.8, pp.725-732, 2002. ,
Sensitization of cancer cells treated with cytotoxic drugs to fasmediated cytotoxicity, J Natl Cancer Inst, vol.89, pp.783-789, 1997. ,
Induction of apoptosis in 9- nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c- FLIP(short), Cancer Res, vol.61, pp.7148-7154, 2001. ,
Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosis, Cancer Biol Ther, vol.6, pp.652-660, 2002. ,
Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs, J Biol Chem, vol.274, pp.7987-7992, 1999. ,
Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression, Cancer Res, vol.61, pp.1314-1319, 2001. ,
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis, Oncogene, vol.19, pp.4563-4573, 2000. ,
The role of caspase-8 in resistance to cancer chemotherapy, Drug Resist Updat, vol.4, pp.293-296, 2001. ,
Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates 10, 2010. ,
Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma, Eur J Cancer, vol.38, pp.83-91, 2002. ,
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines, Cancer Res, vol.62, pp.5897-5901, 2002. ,
Differential inactivation of caspase-8 in lung cancers, Cancer Biol Ther, vol.1, pp.65-69, 2002. ,